Purchases and Sales Made in Q4 2019 in Stealth Bio Therapeutics Corp (MITO)
This table provides information about the institutional ownership of Stealth Bio Therapeutics Corp (MITO) during Q4 2019. The information is specifically focused on institutions that hold shares of Stealth BioTherapeutics Corp.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2020
Q4 2019
|
Brown Brothers Harriman & CO
New York, NY |
BUY
|
- |
175KNew |
$570K - $2.4M
|
175K
$0
|
|
|
Jan 31, 2020
Q4 2019
|
Ikarian Capital, LLC
Dallas, TX |
BUY
|
- |
37.6KNew |
$123K - $515K
|
37.6K
$0
|
|
|
Feb 14, 2020
Q4 2019
|
Ubs Group Ag
|
BUY
|
- |
286+ 4.26% |
$932 - $3.92K
|
7K
$0
|
|
|
Feb 14, 2020
Q4 2019
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 14, 2020
Q4 2019
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-348Closed |
$1.13K - $4.77K
|
0
$0
|
|
|
Feb 14, 2020
Q4 2019
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-26.4KClosed |
$86.2K - $362K
|
0
$0
|
|
|
Feb 14, 2020
Q4 2019
|
Kingdon Capital Management, L.L.C.
New York, NY |
SELL
|
- |
-398KClosed |
$1.3M - $5.45M
|
0
$0
|